Production (Stage)
Entrada Therapeutics, Inc.
TRDA
$7.59
-$0.26-3.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 382.52M | 420.00M | 449.34M | 469.75M | 327.41M |
| Total Receivables | 4.54M | 5.48M | 3.80M | 9.07M | 78.51M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.13M | 14.16M | 12.19M | 10.72M | 8.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 400.00K | -- | -- | -- |
| Total Current Assets | 403.19M | 440.04M | 465.34M | 489.54M | 414.17M |
|
|
|||||
| Total Current Assets | 403.19M | 440.04M | 465.34M | 489.54M | 414.17M |
| Net Property, Plant & Equipment | 79.10M | 82.05M | 84.56M | 87.73M | 89.96M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.19M | 4.23M | 4.70M | 4.70M | 6.71M |
| Total Assets | 486.48M | 526.32M | 554.59M | 581.96M | 510.84M |
|
|
|||||
| Total Accounts Payable | 2.19M | 4.26M | 1.29M | 1.64M | 2.53M |
| Total Accrued Expenses | 6.70M | 12.30M | 12.43M | 10.10M | 8.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.51M | 7.56M | 7.74M | 8.57M | 8.30M |
| Total Finance Division Other Current Liabilities | 3.03M | 15.36M | 49.15M | 65.51M | 155.06M |
| Total Other Current Liabilities | 3.03M | 15.36M | 49.15M | 65.51M | 155.06M |
| Total Current Liabilities | 18.43M | 39.48M | 70.60M | 85.81M | 173.94M |
|
|
|||||
| Total Current Liabilities | 18.43M | 39.48M | 70.60M | 85.81M | 173.94M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 50.49M | 51.65M | 53.58M | 55.88M | 58.13M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 301.00K | 6.51M | 7.96M | 10.35M | 9.41M |
| Total Liabilities | 69.22M | 97.64M | 132.14M | 152.04M | 241.48M |
|
|
|||||
| Common Stock & APIC | 563.52M | 558.07M | 551.95M | 546.70M | 441.09M |
| Retained Earnings | -146.69M | -129.34M | -130.48M | -116.44M | -171.47M |
| Treasury Stock & Other | 437.00K | -43.00K | 972.00K | -329.00K | -246.00K |
| Total Common Equity | 417.26M | 428.68M | 422.45M | 429.93M | 269.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 417.26M | 428.68M | 422.45M | 429.93M | 269.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 417.26M | 428.68M | 422.45M | 429.93M | 269.37M |
|
|
|||||